STK25 and malignant colon neoplasm: LIMK1 is highly expressed by colon cancer tissues, and inhibiting the expression of LIMK1 can reduce the proliferation, invasion and epithelial–mesenchymal transition of colon cancer cells by interacting with STK25 [59].